Propiedad y actividad de insiders de Immuneering Corporation (IMRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $4.45 |
| Capitalización | $162M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-16 | Gengos Andrew | A-Award | 650,000 | $3.1M |
| 2026-07-16 | Gengos Andrew | |||
| 2026-06-23 | Zeskind Benjamin J. | P-Purchase | 2,400 | $11K |
| 2026-06-15 | Hall Brett Matthew | P-Purchase | 6,035 | $25K |
| 2026-06-11 | Schall Thomas J. | A-Award | 33,350 | $137K |
| 2026-06-11 | HAUSMAN DIANA | A-Award | 33,350 | $137K |
| 2026-06-11 | CARPENTER ROBERT J | A-Award | 33,350 | $137K |
| 2026-06-11 | KEATING LAURIE | A-Award | 33,350 | $137K |
| 2026-06-11 | Feinberg Peter | A-Award | 33,350 | $137K |
| 2026-03-13 | Neufeld Leah R | A-Award | 3,628 | $16K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $13.8M | $37.1M | $74.9M | $72.6M | $59.4M | $36.1M | $128.6M |
| Inversiones a Corto | 0 | 0 | $74.3M | $32.9M | $26.3M | 0 | $44.2M |
| Cuentas por Cobrar | $209940 | $500110 | $246040 | $12417 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $14.1M | $37.7M | $152.3M | $108.7M | $89.1M | $39.6M | $176.2M |
| Inmovilizado Material | $35276 | $677466 | $6.1M | $5.8M | $5.4M | $4.8M | $4.3M |
| Fondo de Comercio | 0 | 0 | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M |
| Activos Intangibles | 0 | 0 | $439000 | $408947 | $379680 | $350413 | $321147 |
| Activos Totales | $14.1M | $38.4M | $166.7M | $122.4M | $102.6M | $52.7M | $232.0M |
| Cuentas por Pagar | $294948 | $1.5M | $1.4M | $3.2M | $2.1M | $2.0M | $1.5M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $505296 | $2.3M | $5.6M | $8.1M | $7.8M | $7.5M | $10.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $20.6M | $60.9M | $10.7M | $12.5M | $12.0M | $11.3M | $13.5M |
| Reservas | -$8.7M | -$25.7M | -$59.3M | -$109.8M | -$163.3M | -$224.3M | -$280.3M |
| Patrimonio Neto | -$6.5M | -$22.5M | $156.0M | $109.9M | $90.6M | $41.4M | $218.5M |
| Deuda Total | 0 | $621089 | $5.4M | $4.8M | $4.5M | $4.2M | $3.8M |
| Deuda Neta | -$13.8M | -$36.5M | -$143.8M | -$100.7M | -$81.2M | -$32.0M | -$169.0M |
| Capital Circulante | $13.6M | $35.5M | $146.7M | $100.7M | $81.2M | $32.1M | $166.2M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 19.47 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 11.19 |
Rentabilidad
| Rentabilidad sobre capital | -27.15% |
| Rentabilidad sobre capital invertido | -32.65% |
| Rentabilidad sobre activos | -28.35% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ARCT · ASMB · ENTA · FHTX · HUMA · NAUT · PYXS
Explorar sector: Healthcare · Biotechnology
Más secciones de IMRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones